Feb 12, 2026 08:00AM
Feb 12, 2026 08:00AM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Dec 18, 2025 04:35PM
Nov 18, 2025 08:45AM
Nov 18, 2025 08:00AM Annovis Bio schedules FDA meeting on Parkinson's dementia drug
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Nov 18, 2025 08:00AM
Sep 30, 2025 07:05AM
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM
Jun 5, 2025 08:00AM Annovis to Host Webinar and Live Q&A on June 24, 2025
Jun 5, 2025 08:00AM
Mar 21, 2025 05:05PM
Feb 5, 2025 08:01AM
Feb 5, 2025 08:00AM
Jan 7, 2025 08:01AM
Jan 7, 2025 08:00AM
Jan 7, 2025 08:00AM FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway
Jan 7, 2025 08:00AM
Nov 25, 2024 08:00AM
Nov 11, 2024 08:00AM
Oct 31, 2024 08:00AM
Oct 16, 2024 06:56AM
Oct 15, 2024 08:03AM
Oct 15, 2024 08:00AM FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
Oct 2, 2024 08:30AM
Sep 30, 2024 08:05AM
Sep 30, 2024 08:00AM
Sep 3, 2024 07:22AM
Aug 15, 2024 07:00AM
Aug 6, 2024 09:00AM
Aug 6, 2024 08:30AM Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033   
Jul 16, 2024 08:01AM
Jul 16, 2024 08:00AM
Jul 9, 2024 08:00AM
Jul 2, 2024 08:04AM
Jul 2, 2024 08:00AM
Jul 2, 2024 08:00AM
Jun 26, 2024 08:00AM Annovis Bio (ANVS) Files Patent for New Composition of Matter for Buntanetap
Jun 26, 2024 08:00AM
Jun 26, 2024 08:00AM
Jun 11, 2024 08:00AM
Jun 11, 2024 08:00AM
May 9, 2024 07:30AM
May 9, 2024 07:30AM
May 6, 2024 07:31AM Annovis Bio (ANVS) CEO Issues Letter to Shareholders
May 6, 2024 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All